129 related articles for article (PubMed ID: 35094933)
41. Glassy cell carcinoma of the uterine cervix: 20-year experience from a comprehensive cancer center.
Boustani J; Achkar S; Bertaut A; Genestie C; Gouy S; Pautier P; Morice P; Haie-Meder C; Chargari C
Cancer Radiother; 2021 May; 25(3):207-212. PubMed ID: 33408051
[TBL] [Abstract][Full Text] [Related]
42. Preoperative intracavitary brachytherapy in early-stage cervical carcinoma.
Mundt AJ; Waggoner S; Herbst A; Rotmensch J
Am J Clin Oncol; 1999 Feb; 22(1):73-7. PubMed ID: 10025386
[TBL] [Abstract][Full Text] [Related]
43. Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.
Landoni F; Sartori E; Maggino T; Zola P; Zanagnolo V; Cosio S; Ferrari F; Piovano E; Gadducci A
Gynecol Oncol; 2014 Mar; 132(3):611-7. PubMed ID: 24342439
[TBL] [Abstract][Full Text] [Related]
44. Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancer.
Alektiar KM; McKee A; Venkatraman E; McKee B; Zelefsky MJ; Mychalczak BR; Hoskins WJ; Barakat RR
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):707-13. PubMed ID: 12062616
[TBL] [Abstract][Full Text] [Related]
45. Treatment results of adjuvant pelvic radiotherapy after radical hysterectomy for low-risk Stage IB1-IIA cervical cancer.
Zhao D; Qiu H; Zhang H; Hong L; Zhang G; Xie C
Jpn J Clin Oncol; 2017 Nov; 47(11):1024-1030. PubMed ID: 28973662
[TBL] [Abstract][Full Text] [Related]
46. Vaginal cuff brachytherapy in the adjuvant setting for patients with high-risk early-stage cervical cancer.
Mauro GP; Kleine RT; da Costa SCS; Carvalho HA
Brachytherapy; 2019; 18(6):747-752. PubMed ID: 31607499
[TBL] [Abstract][Full Text] [Related]
47. Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study.
Strauss HG; Kuhnt T; Laban C; Puschmann D; Pigorsch S; Dunst J; Koelbl H; Haensgen G
Strahlenther Onkol; 2002 Jul; 178(7):378-85. PubMed ID: 12163992
[TBL] [Abstract][Full Text] [Related]
48. Class I versus class III radical hysterectomy in stage IB1-IIA cervical cancer. A prospective randomized study.
Landoni F; Maneo A; Zapardiel I; Zanagnolo V; Mangioni C
Eur J Surg Oncol; 2012 Mar; 38(3):203-9. PubMed ID: 22244909
[TBL] [Abstract][Full Text] [Related]
49. The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.
Hwang WY; Kim JH; Suh DH; Kim K; No JH; Kim YB
Int J Gynecol Cancer; 2020 Jul; 30(7):975-980. PubMed ID: 32467336
[TBL] [Abstract][Full Text] [Related]
50. Radiotherapy for Japanese elderly patients with cervical cancer: preliminary survival outcomes and evaluation of treatment-related toxicity.
Yoshida K; Sasaki R; Nishimura H; Miyawaki D; Kawabe T; Okamoto Y; Nakabayashi K; Yoshida S; Sugimura K
Arch Gynecol Obstet; 2011 Oct; 284(4):1007-14. PubMed ID: 21116639
[TBL] [Abstract][Full Text] [Related]
51. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
[No Abstract] [Full Text] [Related]
52. Adjuvant platinum-based chemotherapy for early stage cervical cancer.
Rosa DD; Medeiros LR; Edelweiss MI; Pohlmann PR; Stein AT
Cochrane Database Syst Rev; 2012 Jun; 6(6):CD005342. PubMed ID: 22696349
[TBL] [Abstract][Full Text] [Related]
53. Prognostic factors in definitive radiotherapy of uterine cervical cancer.
Yalman D; Aras AB; Ozkök S; Duransoy A; Celik OK; Ozsaran Z; Haydaroğlu A
Eur J Gynaecol Oncol; 2003; 24(3-4):309-14. PubMed ID: 12807246
[TBL] [Abstract][Full Text] [Related]
54. Early stage cervical cancer with negative pelvic lymph nodes: pattern of failure and complication following radical hysterectomy and adjuvant radiotherapy.
Chen SW; Liang JA; Yang SN; Lin FJ
Eur J Gynaecol Oncol; 2004; 25(1):81-6. PubMed ID: 15053068
[TBL] [Abstract][Full Text] [Related]
55. MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer: the University of Pittsburgh experience.
Gill BS; Kim H; Houser CJ; Kelley JL; Sukumvanich P; Edwards RP; Comerci JT; Olawaiye AB; Huang M; Courtney-Brooks M; Beriwal S
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):540-7. PubMed ID: 25680598
[TBL] [Abstract][Full Text] [Related]
56. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
[TBL] [Abstract][Full Text] [Related]
57. Adaptive 3D image-guided brachytherapy: a strong argument in the debate on systematic radical hysterectomy for locally advanced cervical cancer.
Mazeron R; Gilmore J; Dumas I; Champoudry J; Goulart J; Vanneste B; Tailleur A; Morice P; Haie-Meder C
Oncologist; 2013; 18(4):415-22. PubMed ID: 23568003
[TBL] [Abstract][Full Text] [Related]
58. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
[TBL] [Abstract][Full Text] [Related]
59. Inverse Planned High-Dose-Rate Brachytherapy for Locoregionally Advanced Cervical Cancer: 4-Year Outcomes.
Tinkle CL; Weinberg V; Chen LM; Littell R; Cunha JAM; Sethi RA; Chan JK; Hsu IC
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1093-1100. PubMed ID: 26194683
[TBL] [Abstract][Full Text] [Related]
60. Laparoscopic radical hysterectomy after preoperative brachytherapy for stage IB1 cervical cancer: feasibility, results, and surgical implications in a large bicentric study of 162 consecutive cases.
Uzan C; Merlot B; Gouy S; Belghiti J; Haie-Meder C; Nickers P; Fabrice N; Morice P; Leblanc E
Ann Surg Oncol; 2013 Mar; 20(3):872-80. PubMed ID: 22932859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
